Dose-Response Modeling: Extrapolating From Experimental Data to Real-World Populations

被引:2
|
作者
Pratt, Adrian [1 ]
Bennett, Emma [1 ]
Gillard, Joseph [2 ]
Leach, Steve [1 ]
Hall, Ian [1 ,3 ]
机构
[1] Publ Hlth England, Emergency Response Dept, Porton Down, England
[2] Def Sci & Technol Lab, Salisbury, Wilts, England
[3] Univ Manchester, Dept Math, Oxford Rd, Manchester M13 9PL, Lancs, England
基金
美国国家卫生研究院;
关键词
Competing-risks framework; dose-response modeling; quantitative microbial risk assessment; YERSINIA-PESTIS; PATHOGENESIS; PROPHYLAXIS; ANTHRAX; MICE;
D O I
10.1111/risa.13597
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Dose-response modeling of biological agents has traditionally focused on describing laboratory-derived experimental data. Limited consideration has been given to understanding those factors that are controlled in a laboratory, but are likely to occur in real-world scenarios. In this study, a probabilistic framework is developed that extends Brookmeyer's competing-risks dose-response model to allow for variation in factors such as dose-dispersion, dose-deposition, and other within-host parameters. With data sets drawn from dose-response experiments of inhalational anthrax, plague, and tularemia, we illustrate how for certain cases, there is the potential for overestimation of infection numbers arising from models that consider only the experimental data in isolation.
引用
收藏
页码:67 / 78
页数:12
相关论文
共 50 条
  • [41] Using real-world traffic incident data in transport modeling
    Kaddoura, Ihab
    Nagel, Kai
    9TH INTERNATIONAL CONFERENCE ON AMBIENT SYSTEMS, NETWORKS AND TECHNOLOGIES (ANT 2018) / THE 8TH INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY INFORMATION TECHNOLOGY (SEIT-2018) / AFFILIATED WORKSHOPS, 2018, 130 : 880 - 885
  • [43] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [44] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
  • [45] DOSE-RESPONSE VARIATION AMONG DIFFERENT POPULATIONS
    DARMANSJAH, I
    MUCHTAR, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (05) : 449 - 452
  • [46] Dose-Response Modeling in SBRT COMMENT
    Chowdhry, Amit K.
    Milano, Michael T.
    Soltys, Scott G.
    Grimm, Jimm
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (02): : 609 - 611
  • [47] Dose-Response Modeling in SBRT Reply
    Salans, Mia
    Tibbs, Michelle D.
    Huynh-Le, Minh-Phuong
    Hattangadi-Gluth, Jona A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (02): : 612 - 612
  • [48] Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world data
    Takekita, Yoshiteru
    Hiraoka, Shuichi
    Iwama, Yasuhiro
    Matsui, Daisuke
    Aoki, Nobuatsu
    Ogata, Haruhiko
    Funatsuki, Toshiya
    Shimizu, Toshiyuki
    Murase, Yuji
    Koshikawa, Yosuke
    Kato, Masaki
    Kinoshita, Toshihiko
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (01) : 234 - 239
  • [49] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [50] Inaccurate Real-World Data Does Not Provide Real-World Answers
    Buffet, Gabriela
    Mendoza-Sassi, Raul
    Fysekidis, Marinos
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (05) : E596 - E598